Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2023 Earnings Call Transcript

And number three, we really are seeing growing level of excitement in our later-stage translational clinical partnerships, and are growing increasingly confident in this real clinical opportunity. And so, we’ll look at that in the forthcoming years as real upside to our existing financial model. I think that will really prove to the market that this clinical plan is something real in the near-term. Those are really the sort of the three legs of our growth strategy. And with that, I thank everybody for your time and we look forward to seeing you all soon. Bye.

Operator: Ladies and gentlemen, thank you for participating in today’s conference. This concludes the program. You may now disconnect. Everyone, have a wonderful day.